Skip to content
DraconiticResearch
Search Sources API
203,952 studies31 sourcesUpdated 47 min ago
Peer-reviewedCC BY-NC-ND 4.0The Medical Journal of Australia

The Commercial Determinants of Health: How Clinicians Can Make a Difference

  1. 1University of Sydney Sydney New South Wales Australia
  2. 2Center to End Corporate Harm University of California San Francisco California USA
  3. 3University of Colorado Denver Colorado USA

Abstract

Commercial determinants of health (CDoH) describe the health‐harming products and practices from corporate activities. The rise of global mega‐corporations means these entities have unprecedented power and impact over the public's health and environments, mediated by multi‐pronged influence over individual behaviours, the scientific evidence base, policymakers and regulatory bodies. Clinicians are not immune to corporate reach. Having an umbrella term and dedicated academic focus for CDoH helps us to understand shared industry tactics and develop safeguards to mitigate harms. We encourage clinicians to combine forces with academics and other professionals to counteract the health harms. There are things we can all do.

Related

  1. Does the messenger make the difference? Perceived reliability of health information sources during the COVID-19 pandemic in multi-ethnic Malaysia
    Nicholas Yee Liang Hing, Yew Kong Lee, Hyung Joon Kim +3
    PLOS Global Public HealthPeer-reviewedCC BY 4.0Full textImmunologyEpidemiology & public healthPLOS
  2. Operationalising Critical Health Literacy: Gambling Harm Education & Commercial Health Determinants
    T Mills, J Grimes
    The European Journal of Public HealthPeer-reviewedCC BY-NC 4.0Full textPMCEurope PMC
  3. Introducing the commercial determinants of health: the arms industry as a case
    J Makhoul
    The European Journal of Public HealthPeer-reviewedCC BY-NC 4.0Full textPMCEurope PMC
  4. From evidence to action: lessons on tackling commercial determinants of health locally
    K Kim
    The European Journal of Public HealthPeer-reviewedCC BY-NC 4.0Full textPMCEurope PMC
  5. How are commercial determinants of health problematised in key health and climate policy guidance?
    DW Hunt, BK Matthes, G Bates +1
    The European Journal of Public HealthPeer-reviewedCC BY-NC 4.0Full textPMCEurope PMC
BibTeX
@article{parker2026commercial,
  title = {{The Commercial Determinants of Health: How Clinicians Can Make a Difference}},
  author = {Lisa Parker and Nicholas Chartres and Kellia Chiu and Barbara Mintzes and Lisa Bero},
  journal = {The Medical Journal of Australia},
  year = {2026},
  month = oct,
  doi = {10.5694/mja2.70328},
  url = {https://doi.org/10.5694/mja2.70328},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - The Commercial Determinants of Health: How Clinicians Can Make a Difference
AU  - Lisa Parker
AU  - Nicholas Chartres
AU  - Kellia Chiu
AU  - Barbara Mintzes
AU  - Lisa Bero
PY  - 2026
DA  - 2026/10/25
JO  - The Medical Journal of Australia
DO  - 10.5694/mja2.70328
UR  - https://doi.org/10.5694/mja2.70328
AB  - Commercial determinants of health (CDoH) describe the health‐harming products and practices from corporate activities. The rise of global mega‐corporations means these entities have unprecedented power and impact over the public's health and environments, mediated by multi‐pronged influence over individual behaviours, the scientific evidence base, policymakers and regulatory bodies. Clinicians are not immune to corporate reach. Having an umbrella term and dedicated academic focus for CDoH helps us to understand shared industry tactics and develop safeguards to mitigate harms. We encourage clinicians to combine forces with academics and other professionals to counteract the health harms. There are things we can all do.
SN  - 0025-729X
SN  - 1326-5377
ER  -